Background-To investigate the relation between changes in portal haemodynamics and renal blood flow (RBF) in patients with cirrhosis. Patients/Methods-Twenty patients with cirrhosis and transjugular intrahepatic portosystemic stent-shunts were divided into two groups which were well matched. At (RBF) and an increase in renal resistance.' 2 The reduction in RBF is accompanied by redistribution of intrarenal blood flow from the cortex to the medulla, even in patients without ascites,' and the hepatorenal syndrome is also characterised by constriction of the intralobular and the arcuate arteries.4
Cirrhosis and portal hypertension are characterised by an increase in splanchnic circulation, peripheral vasodilatation and a spectrum of renal abnormalities, manifested in its mildest form by sodium retention and ascites, and in the severe form by the hepatorenal syndrome. The characteristic findings in the renal dysfunction of cirrhosis are a reduction in renal blood flow (RBF) and an increase in renal resistance.' 2 The reduction in RBF is accompanied by redistribution of intrarenal blood flow from the cortex to the medulla, even in patients without ascites,' and the hepatorenal syndrome is also characterised by constriction of the intralobular and the arcuate arteries.4
There is considerable evidence of increased sympathetic nervous activity in patients with cirrhosis and sodium retention. Noradrenaline concentrations reflect sympathetic nervous activity and its concentration in the circulation is a result of overproduction rather than reduced clearance.5 Concentrations of noradrenaline are inversely related to sodium excretion. 6 Lang et al,7 in an animal model, found an acute reduction in RBF following infusion of glutamine into the portal vein. The effect of the infusion was to induce acute hepatocyte swelling and portal hypertension. This was abolished following section of the hepatic vagal fibres and renal denervation. They proposed the existence of a hepatorenal axis controlled by a reflex arc, the afferent limb of which was the hepatic vagal innervation and the efferent limb was the renal sympathetic system. Transjugular intrahepatic portosystemic stent-shunt (TIPSS) is an interventional radiological technique that involves the creation of a fistulous communication between the hepatic and portal veins through the liver parenchyma; this track is supported by an expandable metal stent. TIPSS has been shown to reduce portal hypertension and is effective in controlling variceal haemorrhage and ascites.8 9 Routine portography is performed to ensure adequate shunt function and this involves direct cannulation of the shunt. The shunt can be occluded using an angioplasty balloon, producing a large increase in the portal atrial gradient (PAG) (portal pressure -right atrial pressure). The aim of this study was to investigate the relation between changes in portal haemodynamics and renal blood flow in patients with cirrhosis.
Methods
The study was approved by the local ethics committee and the patients studied gave their informed consent. They were divided into two groups which were studied consecutively. Changes following shunt occlusion were measured either in RBF (group I) or in cardiovascular haemodynamics (group II).
PATIENTS
Patients in the two groups were well matched for age, sex, and aetiology and severity of liver disease. All patients had undergone TIPSS for Portal haemodynamics and renal blood flow in cirrhosis recurrent variceal haemorrhage, one to four months previously. They were recruited into the study when they were attending for portography for the assessment of shunt function. None of the patients had ascites and none were taking diuretics for at least seven days before the study. They had no biochemical evidence of renal failure and their sodium intake was limited to 100 mmol/day.
They were included in the study only if they had no signs of shunt insufficiency at the time of portography which was defined as a portal pressure gradient (portal pressure -inferior vena caval pressure) of less than 12 mm Hg. Table I After measurements at baseline, the angioplasty balloon was inflated and the changes in RBF and other variables as outlined earlier were recorded at two minute intervals for 12 minutes. The balloon was then deflated and variables measured for four minutes at two minute intervals. Renal vein resistance was calculated as the ratio of the RBF to renal vein pressure. 
MEASUREMENT OF CARDIAC HAEMODYNAMICS
Changes in cardiac haemodynamics were measured in patients in group II. The outline of the procedure was similar to that used for the measurement of RBF. A Swan-Ganz catheter was introduced through a sheath in the femoral vein into the pulmonary artery and changes in cardiac output, systemic vascular resistance and pulmonary capillary wedge pressure recorded before and six and 12 minutes after shunt occlusion and after balloon deflation. Three separate recordings were made and the average of these was recorded.
BLOOD SAMPLING AND HORMONAL ASSAYS Plasma was collected from the right atrium and the renal vein, respectively, before and 12 minutes after shunt occlusion and stored at -70°C for analysis at a later date. Although the pulmonary artery would have been ideal for sampling to prevent the effects of streaming and inadequate mixing of blood, the right atrium was chosen because it was thought unethical to introduce another catheter into the pulmonary artery.
Plasma was also collected from a peripherally sited cannula from 12 (eight men) healthy volunteers with a mean (SD) age of 51-3 years who were maintained on a diet containing 80-100 mmol/l sodium for one week.
Measurement ofplasma renin activity (PRA) This radioimmunoassay was based on the principle that angiotensin I is generated by the action of renin on its substrate angiotensinogen. An in-house antibody for angiotensin I was used. Coefficient of variation for the assay was 5 2/2%. Normal range for PRA was 1-6 (±1-5) ng/mllhour for patients on 80-100 mmol/l sodium (no added salt diet).
Measurement of angiotensin II Samples of blood were obtained in angiotensin II inhibitor. Angiotensin II values were measured by radioimmunoassay with an inhouse rabbit antibody R6B4. Coefficient of variation for the assay was 3-2%. Normal range for angiotensin II was 0-032 (±0 01) ng/ml.
Measurement of atrial natriuretic peptide (ANP)
The radioimmunoassay was performed using an antibody to human ANP that had been raised in rabbit after immunisation with human ANP. Coefficient of variation for the assay was 9-8%. Normal range for ANP was 52-3 (range 0-100) pg/ml. 
Measurement of adrenaline and noradrenaline
Extracted samples were assayed using high performance liquid chromatography and electrochemical detection." Coefficients of variation were less than 10% and the normal values for adrenaline and noradrenaline were less than 0 4 and 5 nmol/l, respectively.
STATISTICAL ANALYSIS
Results are expressed as mean (SD) unless otherwise specified. Differences between groups were calculated using the unpaired t test. The relations between variables were calculated using linear regression. were not statistically significant (Table III) . Significant correlation was observed between changes in renal blood flow and the change in renal vascular resistance (r=-0 88, p<00005).
CHANGES IN CARDIAC HAEMODYNAMICS
Cardiac output was reduced from a mean of 7-4 (1 3) /min before shunt occlusion to 6-5 (1) /min 12 minutes after shunt occlusion (p=0-02). This returned to pre-occlusion values after balloon deflation (Fig 3) (Table IV) .
Mean change was -0-85 (0 55) /min (-109 (6&9)%). Shunt occlusion was associated with a significant increase in the PAG (p<00001).
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This was not associated with any significant change in the heart rate, mean arterial pressure ion.
or right atrial pressure. Shunt occlusion was associated with an insignificant reduction in the pulmonary capillary wedge pressure rtal vein (p=0 06). Systemic vascular resistance (SVR) 'min. No increased significantly from 1128 (270 6) to between 1347 (356-4) dyne sec/cm5 (p=002). There pressure was, however, no significant correlation bewas 289 tween the changes in the SVR and the changes inversely in the cardiac output (r=0 4, p=0 24). The ?<0-02). change in cardiac output was also independent of the changes in the PAG (r=0 5, p=0 09).
CHANGES IN RBF
After shunt occlusion, there was a progressive reduction in RBF (p<0 001) which was most noticeable at 12 minutes (Fig 2; Table III) 
CHANGES IN THE NEUROHORMONAL PROFILE
Blood for the measurement of neurohormonal factors was obtained from group I patients. Concentrations of the different factors in the renal and systemic circulation before and after shunt occlusion are summarised in Table V. Systemic concentrations of PRA, angiotensin II, and cGMP were significantly higher in the patients compared with controls (p<0 04, p<002 and p<001, respectively). There was no significant difference in the adrenaline, noradrenaline, and ANP concentrations in the patients compared with age and sex matched healthy volunteers.
Concentrations of cGMP and noradrenaline were significantly higher in the renal compared with the systemic circulation (p<001 and p<002, respectively). PRA was significantly lower (p<0.04) and there was no significant difference in the concentrations of angiotensin II, ANP and adrenaline in the systemic and the renal circulations. After shunt occlusion, there was no significant change in the concentration of any of these variables in the systemic or the renal circulations.
Discussion
This study shows that there is a dramatic reduction in RBF after acute increase in the PAG. This change is not related to alteration in the mean arterial pressure, heart rate or the right atrial pressure. The relation between changes in RBF and cardiac output would ideally have been studied in the same patient 1  254  200  4  2  75  77  98  94  3  4  8  36  2  265  235  1  1  99  95  94  94   -3   -4  10  44  3  464  247  11  8  72  70  99  94  3  5  11  53  4  153  121  8  7  76  69  107  97  6  7  12  35  5  128  98  5  3  89  82  107  99  1  -1  7  45  6  320  91  8  6  70  52  77  78  6  5  6  67  7  310  87  11  8  93  88  102  96  6  4  6  58  8  251  53  0  -1  74  76  92  89  -3  -1  9  60  9  351  140  7  4  88  68  77  85  0  0  8  58  10  395  281  8  5  64  60  110  116  7  5  6  50 Mean (6-9)%) were statistically significant, this change was not sufficient to explain the magnitude of the change in RBF (-43 5 (25-3)%). Furthermore, the changes in cardiac output were not associated with any significant disturbance in the mean arterial pressure which is of paramount importance in the perfusion of the kidneys. Several theories regarding the initiation of renal vasoconstriction in cirrhosis have been proposed. The underfill hypothesis"3 gave way to the overfill hypothesis,'4 which has been replaced by the peripheral vasodilatation theory.'5 According to this theory, the initiating event is splanchnic vasodilatation and portal hypertension produced by the action of splanchnic vasodilators upon the portal and systemic circulation as a result of reduced increase in PAG and renal resistance suggests the existence of a signalling mechanism between the liver and the kidney.
TIPSS has been shown to be effective in the treatment of the hepatorenal syndrome.30 31 The mechanism of this improvement is not entirely clear but the results of this study provide some clues. The reduction in portal pressure gradient by the introduction of TIPSS may be envisaged to increase RBF through the hepatorenal axis and therefore improve renal perfusion, creatinine clearance and sodium excretion.
Ideally, the systemic samples for the measurement of neurohormonal factors should have been collected from the pulmonary artery to avoid the problems of streaming and inadequate mixing. This streaming effect and poor mixing may be responsible for the higher values of ANP found in the renal vein rather than in the right atrium. (ANP is produced in orificium of the coronary sinus and then secreted into the right atrium.) Similarly, the kidneys are important in the production of renin. Higher concentrations of renin are therefore expected in the renal circulation. The finding of higher values of renin in the right atrium in this study may be related to the mixing problem.
The higher cGMP concentration in the systemic circulation probably reflects increased nitric oxide activity because the ANP concentrations were normal. Normal adrenaline and noradrenaline concentrations in these patients may reflect adequate shunt function and the absence of ascites. Notably, higher concentrations of noradrenaline (vasoconstrictor) and cGMP (reflecting nitric oxide activityvasodilator) in the renal circulation may represent the reciprocal role of these substances in the regulation of RBF. Insignificant change in the ANP concentration argues against the change in RBF being the result of a significant alteration in the circulating volume. Similarly, the renin-angiotensin system has not been implicated in the mediation of this phenomenon. These observations suggest that these hormonal factors do not have an important role in modulating the change in RBF and point to the existence of a hepatorenal axis in the mediation of this phenomenon.
It was therefore somewhat surprising that the concentrations of adrenaline and noradrenaline were not significantly different before and after shunt occlusion. This may either be because of the limit of detectability of the assay used or to the rapid uptake and breakdown of these catecholamines by synaptic monoamine-oxidase inhibitors and catecholamine-0-methyl transferases. The problems of streaming and inadequate mixing of blood in the renal vein and the right atrium may be partially responsible for the normal values of adrenaline and noradrenaline observed.
Electrophysiological or pharmacological studies are required for the confirmation of the role of the sympathetic system as an effector arm of this phenomenon. It is also possible that this phenomenon may be mediated by other intrarenal factors described earlier. Further studies are required to ascertain the role of these factors in the mediation of this phenomenon which may be important in the pathogenesis of the hepatorenal syndrome.
The contribution of the reduction in cardiac output following shunt occlusion to the reduction in RBF cannot be disregarded.
Occlusion of TIPSS seems to induce a decrease in venous return and, therefore, possibly re-distribution in blood flow. However, the change in cardiac output did not produce any significant haemodynamic disturbance. The transient increase in RBF between two and four minutes in three patients after inflation of the balloon is difficult to explain but further argues against a significant role of reduction in cardiac output being important in the change in RBF. Unfortunately, in this study we have not measured changes in cardiac output at these time points. The statistical insignificance of the change in mean arterial pressure is unlikely to be because of the number ofpatients studied in each group as the difference remained inconsequential even when changes in both groups were considered together. Finally, as pointed out earlier, the degree of reduction in cardiac output cannot fully explain the changes in RBF.
In conclusion, we have demonstrated a dramatic reduction in RBF with acute increase in PAG which is compatible with the existence of hepatorenal reflex in man, although other mechanisms may also be contributory. This is a reproducible model which can be used to study this phenomenon further, improve our understanding of the changes in renal circulation in liver disease, thereby providing clues for the development of new treatments.
